CaSE are delighted to welcome the University of Leeds and the Engineering Professors' Council as new organisational members.
CaSE has published its representation ahead of the the Government's Autumn Budget 2018
CaSE has today responded to the 2018 Autumn Budget.
Read our summary of a recent high-level CaSE member meeting on R&D investment with UKRI Chair, Sir John Kingman
CaSE has published a one page briefing setting out the scale of public and private investment needed to reach the Government's target of total R&D spending reaching 2.4% of GDP on R&D by 2027 and 3% in the long-term.
CaSE has published a one page briefing setting out the scale of public and private funding needed to reach the Government's target of 2.4% of GDP on R&D by 2027 and 3% in the long-term
Read CaSE's evidence to the House of Commons Science and Technology Committee inquiry into the balance and effectiveness of research and innovation spending.
Jeremy Clayton is a member of the CaSE Board of Directors and was previously BIS Director responsible for research funding and policy during the Coalition Government. As the 2019 Spending Review approaches, he reflects on how best to influence key decision-makers.
This report finds the business performance effects of publicly funded research grants.
We review the MAC's report and discuss what their recommendations could mean for the future of UK immigration
Anne Barrett looks at how the Government is communicating its support for research and innovation
The findings of the Government commissioned report on EEA workers in the UK.
With the Migration Advisory Committee publishing their latest report on the shape of a future migration system post-Brexit, CaSE has written to the Home Secretary and published new FOI data on Tier 2 visa refusals
CaSE has published a joint letter to the Home Secretary with the BioIndustry Association and TechUK, cautioning over an expansion of the non-EEA migration system.
The findings of the Government commissioned report on international students in the UK.
A second FOI request by CaSE means we can now paint the complete picture of the effect the Tier 2 cap has had on UK employers and highly skilled individuals.
CaSE are delighted to welcome Richmond Pharmacology as new organisational members.
CaSE has published its Annual Review for 2017-18, giving a summary of its activities and campaign achievements over the last 12 months.
James Tooze reflects on Scottish exam results day.